Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,046 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges.
Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O'Connor CM. Zannad F, et al. Among authors: goldstein s. Int J Cardiol. 2013 Sep 1;167(5):1772-82. doi: 10.1016/j.ijcard.2012.12.018. Epub 2013 Jan 6. Int J Cardiol. 2013. PMID: 23298559 Review.
The current role of digoxin in the treatment of heart failure.
Smith JR, Gheorghiade M, Goldstein S. Smith JR, et al. Among authors: goldstein s. Coron Artery Dis. 1993 Jan;4(1):16-26. doi: 10.1097/00019501-199301000-00003. Coron Artery Dis. 1993. PMID: 8269181 Review. No abstract available.
Beta-blockers in the post-myocardial infarction patient.
Gheorghiade M, Goldstein S. Gheorghiade M, et al. Among authors: goldstein s. Circulation. 2002 Jul 23;106(4):394-8. doi: 10.1161/01.cir.0000019582.39797.ef. Circulation. 2002. PMID: 12135934 No abstract available.
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.
Verheugt FW, Clemmensen P, Mehran R, Agewall S, Pocock SJ, Goldstein S, Torp-Pedersen C, Simoons ML, Borer JS, Khder YM, Burton P, Deliargyris E, McMurray JJ, Berkowitz SD, Stough WG, Zannad F. Verheugt FW, et al. Among authors: goldstein s. Eur Heart J. 2013 Jun;34(22):1621-9. doi: 10.1093/eurheartj/eht013. Epub 2013 Feb 4. Eur Heart J. 2013. PMID: 23382466 No abstract available.
Digoxin for chronic heart failure: a review of the randomized controlled trials with special attention to the PROVED (Prospective Randomized Study of Ventricular Failure and the Efficacy of Digoxin) and RADIANCE (Randomized Assessment of Digoxin on Inhibitors of the angiotensin Converting Enzyme) trials.
Tauke J, Goldstein S, Gheorghiade M. Tauke J, et al. Among authors: goldstein s. Prog Cardiovasc Dis. 1994 Jul-Aug;37(1):49-58. doi: 10.1016/s0033-0620(05)80051-9. Prog Cardiovasc Dis. 1994. PMID: 8022986 Review. No abstract available.
Subgroup analysis of clinical trials.
Gheorghiade M, Schultz L, Tilley B, Kao W, Goldstein S. Gheorghiade M, et al. Among authors: goldstein s. Am J Cardiol. 1991 Feb 1;67(4):330-2. doi: 10.1016/0002-9149(91)90595-c. Am J Cardiol. 1991. PMID: 1671316 No abstract available.
Implications of geographical variation on clinical outcomes of cardiovascular trials.
Mentz RJ, Kaski JC, Dan GA, Goldstein S, Stockbridge N, Alonso-Garcia A, Ruilope LM, Martinez FA, Zannad F, Pitt B, Fiuzat M, O'Connor CM. Mentz RJ, et al. Among authors: goldstein s. Am Heart J. 2012 Sep;164(3):303-12. doi: 10.1016/j.ahj.2012.06.006. Epub 2012 Aug 3. Am Heart J. 2012. PMID: 22980295 Review.
3,046 results